copeptin C-terminal
Selected indexed studies
- Potential Clinical Utility of Copeptin (C-terminal provasopressin) measurements in clinical medicine. (Exp Clin Endocrinol Diabetes, 2016) [PMID:27008633]
- Polyuria-polydipsia syndrome: a diagnostic challenge. (Intern Med J, 2018) [PMID:28967192]
- [Copeptin - stable C-terminal fragment of pre-provasopressin as a new stress marker in newborns]. (Postepy Hig Med Dosw (Online), 2015) [PMID:26206985]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Polyuria-polydipsia syndrome: a diagnostic challenge. (2018) pubmed
- Potential Clinical Utility of Copeptin (C-terminal provasopressin) measurements in clinical medicine. (2016) pubmed
- [Copeptin - stable C-terminal fragment of pre-provasopressin as a new stress marker in newborns]. (2015) pubmed
- The Circadian Rhythm of Copeptin, the C-Terminal Portion of Arginine Vasopressin. (2017) pubmed
- Copeptin (C-terminal provasopressin): a promising marker of arrhythmogenesis in arrhythmia prone subjects? (2011) pubmed
- C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. (2007) pubmed
- Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction. (2015) pubmed
- C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. (2009) pubmed
- C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study. (2011) pubmed
- C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction. (2008) pubmed